Immuron Limited (IMRN): Price and Financial Metrics

Immuron Limited (IMRN)

Today's Latest Price: $2.12 USD

0.02 (0.95%)

Updated May 29 12:01pm

Add IMRN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

IMRN Stock Summary

  • IMRN has a market capitalization of $8,568,825 -- more than approximately merely 5.15% of US stocks.
  • For IMRN, its debt to operating expenses ratio is greater than that reported by merely 0.34% of US equities we're observing.
  • With a year-over-year growth in debt of -100%, Immuron Ltd's debt growth rate surpasses only 0% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Immuron Ltd are GIGM, ASYS, MTSL, MGIC, and JOUT.
  • IMRN's SEC filings can be seen here. And to visit Immuron Ltd's official web site, go to
IMRN Daily Price Range
IMRN 52-Week Price Range

IMRN Stock Price Chart More Charts

IMRN Price/Volume Stats

Current price $2.12 52-week high $7.25
Prev. close $2.10 52-week low $1.55
Day low $2.12 Volume 936
Day high $2.15 Avg. volume 19,628
50-day MA $2.11 Dividend yield N/A
200-day MA $3.00 Market Cap 7.59M

Immuron Limited (IMRN) Company Bio

Immuron Limited focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company was founded in 1994 and is based in Australia.

IMRN Latest News Stream

Event/TimeNews Detail
Loading, please wait...

IMRN Latest Social Stream

Loading social stream, please wait...

View Full IMRN Social Stream

Latest IMRN News From Around the Web

Below are the latest news stories about Immuron Ltd that investors may wish to consider to help them evaluate IMRN as an investment opportunity.

Immuron Board Relinquish Cash Payment of Fees

Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the treatment of gut mediated diseases, today announced that the cash payments of Board fees will be suspended and replaced with Immuron stock. As announced to the market on 25 March, 2020 the Board and Executive Management reported that significant cost reductions measures have been implemented to preserve the Company’s cash position. As part of these measures, Immuron’s Board of Directors (‘the Board’) have resolved, for the foreseeable future, to relinquish cash payments of fees and in lieu of same receive common stock in the Company.

Yahoo | April 28, 2020

Immuron North American Travelan® Sales Up 95%, Global Sales Up 60%

Immuron achieved 60% YoY growth in worldwide product sales in Q3 FY20. YTD March 31, FY20 worldwide sales reached AU $2.67M, increasing 57% YoY. In Australia, Q3 FY20 gross sales grew by 35% YoY to $475K.

Yahoo | April 20, 2020

The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down

Here's a roundup of top developments in the … Full story available on

Benzinga Feeds | March 25, 2020

A Look At Benzinga Pro's Most-Searched Tickers For October 14, 2019

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Synthesis Energy Systems (NASDAQ: SES ) shares ...

Yahoo | October 14, 2019

Immuron North American Q1 Sales Up 111% YoY

Key Highlights: First Quarter of FY2020 (Q1) North American sales grew by 111% YoY to $269K AUDQ1 US Travelan® sales increased by +81% YoY to $232K AUDGlobal Immuron sales.

Yahoo | October 14, 2019

Read More 'IMRN' Stories Here

IMRN Price Returns

1-mo -16.21%
3-mo -34.77%
6-mo -41.76%
1-year -39.31%
3-year N/A
5-year N/A
YTD -41.60%
2019 N/A
2018 0.00%
2017 N/A
2016 N/A
2015 N/A

Continue Researching IMRN

Want to see what other sources are saying about Immuron Ltd's financials and stock price? Try the links below:

Immuron Ltd (IMRN) Stock Price | Nasdaq
Immuron Ltd (IMRN) Stock Quote, History and News - Yahoo Finance
Immuron Ltd (IMRN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7877 seconds.